AMD to Acquire Fei-Fei Li’s World Labs for $8.2 Billion
AMD will purchase World Labs for $8.2 billion, with founder Fei‑Fei Li joining the company as executive vice president and chief scientist.
AMD has confirmed a deal to acquire World Labs, the AI research startup founded by renowned computer scientist Fei‑Fei Li, for a reported $8.2 billion. The transaction, announced on September 28, 2026, marks one of the largest AI‑focused acquisitions of the year.
As part of the agreement, Fei‑Fei Li will transition to AMD as executive vice president and chief scientist, positioning her to steer the combined entity’s research agenda and product strategy. Her role is expected to integrate World Labs’ cutting‑edge AI capabilities with AMD’s hardware portfolio.
The acquisition underscores AMD’s ambition to deepen its presence in the artificial‑intelligence market, leveraging Li’s expertise and World Labs’ technology stack. Industry observers note that the move could accelerate AMD’s development of AI‑optimized processors and software tools.
Details of the deal were reported by TechCrunch AI, which highlighted the strategic fit between AMD’s compute platforms and World Labs’ research output. No further financial terms or integration timelines were disclosed beyond the headline purchase price.
The partnership is set to unfold in the coming months, with AMD and World Labs teams collaborating on joint projects aimed at advancing AI research and commercial applications.
Read also
OpenAI Won’t IPO Until Model Safety Is Proven, Says Altman
OpenAI's chief executive Sam Altman announced that the firm will postpone any public offering until it can make more concrete assurances about the safety of its AI models.
Google Trials Gemini-Powered Purchases on Flipkart in India
Google is running a limited test that lets Indian users purchase select Flipkart products via Gemini and AI Mode, with plans to expand later this month.
Insurers Say AI Tools Add $942M to Hospital Costs
Blue Cross Blue Shield says AI usage in hospitals added $942 million to healthcare costs over a two‑year span, prompting insurers to warn of rising expenses.
